Hotline:
+ 49 (0) 2204 2918806

Market studies for category Ophthalmology

Items 1 to 10 of 88 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  1. Net price*
    Year
  2. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

    Global Markets Direct
    127 pages
    Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014’, provides an overview of the Retinitis Pigmentosa (Retinitis)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Retinitis Pigmentosa (Retinitis), complete with comparative analysis at variou
    Englisch | Zukunftsanalyse | SKU: 987671818
  3. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Abicipar Pegol (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

    GlobalData
    109 pages
    Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO). Age-related macular degeneration (AMD) is a
    Englisch | Zukunftsanalyse | SKU: 987678516
  4. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Optina (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

    GlobalData
    109 pages
    Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO). Age-related macular degeneration (AMD) is a
    Englisch | Zukunftsanalyse | SKU: 987678521
  5. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Retinopathy - Pipeline Review, H2 2014

    Global Markets Direct
    39 pages
    Global Markets Direct’s, ‘Retinopathy - Pipeline Review, H2 2014’, provides an overview of the Retinopathy’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Retinopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of
    Englisch | Zukunftsanalyse | SKU: 987671823
  6. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Uveitis Global Clinical Trials Review, H1, 2013

    GlobalData
    107 pages
    Introduction GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H1, 2013" provides data on the Uveitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uveitis. It includes an overview of the trial numbers and their recruitment status as per the site
    Englisch | Report | SKU: 330107
  7. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Retinal Vein Occlusion - Pipeline Review, H1 2014

    Global Markets Direct
    63 pages
    Global Markets Direct’s, ‘Retinal Vein Occlusion - Pipeline Review, H1 2014’, provides an overview of the Retinal Vein Occlusion’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Retinal Vein Occlusion, complete with comparative analysis at various stages, therapeutics assessm
    Englisch | Zukunftsanalyse | SKU: 393782
  8. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Posterior Uveitis - Pipeline Review, H1 2015

    Global Markets Direct
    57 pages
    Global Markets Direct’s, ‘Posterior Uveitis - Pipeline Review, H1 2015’, provides an overview of the Posterior Uveitis’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Posterior Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug tar
    Englisch | Zukunftsanalyse | SKU: 987688210
  9. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Optic Neuropathy - Pipeline Review, H2 2014

    Global Markets Direct
    49 pages
    Global Markets Direct’s, ‘Optic Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Optic Neuropathy’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Optic Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target
    Englisch | Zukunftsanalyse | SKU: 987671828
  10. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Ocular Hypertension - Pipeline Review, H1 2014

    Global Markets Direct
    121 pages
    Global Markets Direct’s, ‘Ocular Hypertension - Pipeline Review, H1 2014’, provides an overview of the Ocular Hypertension’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Ocular Hypertension, complete with comparative analysis at various stages, therapeutics assessment by dr
    Englisch | Zukunftsanalyse | SKU: 393999
  11. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Retinal Degeneration - Pipeline Review, H1 2015

    Global Markets Direct
    82 pages
    Global Markets Direct’s, ‘Retinal Degeneration - Pipeline Review, H1 2015’, provides an overview of the Retinal Degeneration’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Retinal Degeneration, complete with comparative analysis at various stages, therapeutics assessment by
    Englisch | Zukunftsanalyse | SKU: 987688354

Items 1 to 10 of 88 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9